REGENERON PHARMACEUTICALS, INC. (REGN) › Cost of RevenueREGENERON PHARMACEUTICALS, INC. (REGN) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2018: $237.50M2019: $402.80M$402.80M2018Cost of Revenue (USD)2019Fiscal YearCost of RevenueChange YoY2019$402.80M+69.6%2018$237.50M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share